Royce & Associates’s Alvotech ALVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.82M Buy
658,187
+100,043
+18% +$438K 0.03% 531
2026
Q2
$2.06M Buy
+558,144
New +$2M 0.02% 608
2025
Q4
– Sell
-124,346
Closed -$1.02M – 764
2025
Q3
$1.02M Sell
124,346
-148,728
-54% -$1.27M 0.01% 665
2025
Q2
$2.49M Buy
273,074
+102,031
+60% +$958K 0.03% 570
2025
Q1
$1.65M Buy
171,043
+12,043
+8% +$146K 0.02% 617
2024
Q4
$2.1M Buy
159,000
+28,000
+21% +$345K 0.02% 623
2024
Q3
$1.56M Buy
131,000
+37,000
+39% +$429K 0.01% 662
2024
Q2
$1.14M Buy
+94,000
New +$1.26M 0.01% 701

Other funds holding ALVO

Royce & Associates's ALVO Position: Q3 2026 in Review

Royce & Associates increased its Alvotech (ALVO) stake by 18% in Q3 2026, buying an estimated $438K and bringing the position to 658,187 shares worth $3.82M. The position accounts for 0.03% of the portfolio, ranked #531.

Royce & Associates first reported a position in ALVO in Q2 2024 and has held it in 8 quarters since. 56 funds tracked by Wall St. Rank hold ALVO as of Q3 2026.

  • Royce & Associates held 658,187 shares of Alvotech worth $3.82M as of Q3 2026.
  • Royce & Associates bought 100,043 Alvotech shares in Q3 2026, an estimated $438K.
  • Alvotech made up 0.03% of Royce & Associates's portfolio in Q3 2026, its #531 holding.
  • Royce & Associates first reported a position in Alvotech in Q2 2024 and has held it in 8 quarters since.
  • 56 funds tracked by Wall St. Rank held Alvotech as of Q3 2026.

Based on Royce & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.